BRCA test ( BRCAMap)

BRCA Test (BRCAMap)

Mutations in the BRCA1 and BRCA2 genes are among the most well-known hereditary risk factors for breast and ovarian cancer. Women who carry a BRCA1 mutation have up to a 72% lifetime risk of developing breast cancer, compared to around 12% in the general population. Yet most people with these mutations don’t know they carry them — until a diagnosis arrives.

What Is BRCAMap?

BRCAMap by MapmyGenome is a targeted hereditary cancer genetic test that screens for pathogenic variants in the BRCA1 and BRCA2 genes. It is designed for individuals with a personal or family history of breast, ovarian, or related cancers, and for those who want to understand their hereditary cancer risk proactively.

Is This Test Relevant to You? A Quick Self-Check

Consider genetic testing for hereditary cancer risk if any of the following apply to you or your close family:

• A parent, sibling, or child diagnosed with breast or ovarian cancer, especially before age 50

• Multiple family members on the same side with breast, ovarian, prostate, or pancreatic cancer

• A personal or family history of breast cancer in both breasts, or in both a man and a woman in the same family

• Ashkenazi Jewish ancestry, which carries a higher baseline BRCA mutation prevalence

• A family member who has already tested positive for a BRCA1/BRCA2 mutation

What Happens After You Test

• A positive result doesn’t mean cancer is inevitable — it means earlier and more frequent screening, and in some cases preventive options, become part of an informed care plan

• A negative result for a known family mutation is genuinely reassuring, though it doesn’t rule out all cancer risk from other causes

• Either way, results come with genetic counselling, so you’re interpreting them with guidance rather than alone